Genmab

Genmab is a global biotechnology company dedicated to improving the lives of patients through innovative and differentiated antibody therapeutics. Founded in 1999, the company has built a strong track record of discovering and developing innovative medicines targeting cancer and other serious diseases. Genmab's commitment to innovation is reflected in its four proprietary technology platforms: DuoBody®, HexaBody®, HexElect®, and DuoHexaBody®, which enable the development of next-generation antibody therapeutics. The company has eight approved medicines incorporating Genmab innovation, with multiple proprietary clinical programs and a robust pre-clinical pipeline.

Beyond its scientific achievements, Genmab prioritizes sustainability, social responsibility, and diversity, equity, and inclusion (DE&I). The company is committed to making a positive impact on the communities where it operates through its charitable giving, employee volunteer programs, and environmental initiatives. Genmab's culture is focused on empowerment, care, authenticity, and impact, fostering a welcoming and inclusive environment where employees can thrive. The company has four international locations: Princeton (N.J.), United States; Tokyo, Japan; Utrecht, Netherlands; and Copenhagen, Denmark, and employs over 2,000 people globally.

Genmab offers a variety of flexible work arrangements to meet the needs of its employees. The company has four international locations, but many roles are remote. It offers work-life balance benefits such as parental leave, adoption and surrogacy benefits, flexible work arrangements, and backup child care. Genmab also prioritizes employee well-being by offering access to coaching, counseling, and a company hotline.

Genmab offers a comprehensive benefits package designed to support employees' physical, social, professional, emotional, and financial well-being. They provide market-competitive healthcare plans, access to online fitness programs, and paid time off. Genmab also fosters a learning culture with opportunities for professional development through employee resource groups and recognition programs. Additionally, they provide access to coaching and counseling, financial security with retirement plans, life and disability insurance, and a competitive salary with performance-based bonuses.

Genmab is a global biotechnology company dedicated to improving the lives of patients suffering from cancer and other serious diseases. Driven by their purpose to unlock the full potential of antibody science, they strive to create and develop innovative antibody-based products. Genmab is committed to being a sustainable and socially responsible company, fostering a diverse and inclusive workplace, and collaborating with partners to achieve their vision of transforming lives through the power of antibodies.

Genmab promotes a culture that is candid, impact-driven, and unconventional. They embrace diversity and encourage employees to bring their authentic selves to work. They believe in empowering their employees to innovate, build solutions, and execute, and they strive to create a supportive and caring environment where everyone feels valued and connected to the company's mission.

Genmab is committed to fostering a global, inclusive culture where differences are valued and drive innovation. Their Diversity, Equity and Inclusion (DE&I) strategy aims to make Genmab an "extra[not]ordinary®" employer by ensuring equitable access to employment opportunities, raising cultural intelligence, building DEI competency, improving the employee experience, and creating opportunities for connection across the company. This commitment is reflected in their Employee Resource Groups (ERGs) like GenPride, NextGen, Community of Caregivers, GenWEN, MEAD, and GenDads, which enhance company culture and business outcomes by leveraging diversity and inclusion.